The latest report by IMARC Group, titled “ Hemostats Market : Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032“, The global hemostats market size reached US$ 3.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 5.8 Billion by 2032, exhibiting a growth rate (CAGR) of 5.73% during 2024-2032.
Hemostats are specialized surgical tools designed to control bleeding during various medical procedures. These precision instruments are widely used in surgical settings to clamp and secure blood vessels, tissues, or other structures to prevent excessive bleeding. They temporarily block blood flow, allowing surgeons to work on delicate procedures with minimal blood loss. Hemostats are produced from high-quality stainless steel, ensuring durability and resistance to corrosion. Additionally, they are an essential component of any surgical toolkit and are utilized in numerous medical disciplines, including general surgery, orthopedics, and cardiovascular surgery. At present, hemostats are available in various shapes and sizes, most common being straight or curved, locking or non-locking, and mosquito or Kelly clamps.
For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/hemostats-market/requestsample
Hemostats Market Trends and Drivers:
The hemostats market is primarily driven by the rising number of surgical procedures. In addition, the escalating demand for various surgical interventions, including complex procedures, led to the adoption of hemostats to control bleeding during surgery, making them an indispensable tool in modern medicine, thus influencing market growth. Moreover, several advancements in healthcare infrastructure led to better access to healthcare services, which is increasing the number of surgeries performed and enhancing the quality of care provided, thus representing another major growth-inducing factor. Besides this, the growing incidences of chronic medical conditions, such as cardiovascular diseases and cancer, requiring surgical interventions are accelerating the sales demand. Along with this, patients with chronic illnesses have complex health profiles that require more extensive surgeries and hemostatic agents to minimize bleeding complications, thus propelling the market growth. Furthermore, the extensive use of hemostats in trauma and emergency care due to the growing number of accidents and traumatic injuries requires reliable products in emergency rooms and ambulances, thus creating a positive market outlook.
Report Segmentation:
The report has segmented the market into the following categories:
Breakup by Product:
- Thrombin Based
- Combination Based
- Oxidized Regenerated Cellulose Based
- Gelatin Based
- Collagen Based
Breakup by Application:
- Orthopedic Surgery
- General Surgery
- Neurological Surgery
- Cardiovascular Surgery
- Reconstructive Surgery
- Gynecological Surgery
- Others
Breakup by Formulation:
- Matrix and Gel Hemostats
- Sheet and Pad Hemostats
- Sponge Hemostats
- Powder Hemostats
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Competitive Landscape with Key Player:
- Arch Therapeutics Inc.
- Baxter International Inc.
- B. Braun Melsungen Aktiengesell
- C. R. Bard Inc.
- GELITA MEDICAL GmbH
- Integra LifeSciences Corporation
- Johnson Johnson
- Pfizer Inc.
- Stryker Corporation
- Teleflex Incorporated
- Z-Medica LLC
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 |
United Kingdom: +44-753-713-2163
